Caribou Biosciences' revenue growth is promising but rising ...
Caribou Biosciences' revenue growth is promising but rising cash burn rate could concern investors. Raising more capital may result in shareholder dilution, making the situation risky.
![](https://pubimg-10000538.picsh.myqcloud.com/20220509000001532ac4af7ee55.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment